Jeffrey's practice is devoted to all aspects of commercialization of technology. As a scientist/inventor, entrepreneur and counselor, Jeffrey has experience from all of these perspectives. His practice includes corporate counseling, formation and execution of intellectual property strategy, and patent prosecution and opinion work in the areas of chemistry, pharmaceuticals, biotechnology, health & beauty, agriculture, animal health, nutraceuticals, polymers, diagnostics, and medical devices. He also advises on issues of, and is experienced in establishing infrastructure for, development of intellectual property.
Jeffrey's clients include multinational chemical and pharmaceutical companies, emerging biopharmaceutical companies, venture capital and financial institutions, and academic and governmental research institutions throughout the world.
Jeffrey also serves as Co-Chair of the Firm's Intellectual Property Department and serves on the Firm's West Palm Beach/Miami Offices Diversity and Inclusion Committee.
•Jeffrey has considerable experience in patent prosecution matters. He has prepared and prosecuted patent applications relating to pharmaceuticals (both approved and candidates in clinical trials), drug design/discovery technologies, nutraceuticals, medical diagnostics and biotechnology. Jeffrey also is experienced in specialty chemical and polymer technologies, medical devices, food and agricultural technologies and business methods.
•Jeffrey also has experience in transactional matters including negotiation and establishment of licensing and R&D collaboration agreements, manufacturing and supply agreements, due diligence studies, venture capital funding, merger and acquisition, and technology acquisitions.
•As in-house counsel to a biopharmaceutical start-up company, Jeffrey established and guided the company's patent law department, including formation of worldwide corporate intellectual property strategy and internal intellectual property policies. Jeffrey also advised on aspects of corporate and business development activities. The start-up was ultimately acquired by a major U.S. biotechnology company.
•Jeffrey is an invited speaker internationally on various intellectual property issues and has lectured at the Harvard Extension School and at MIT Sloan School of Management.
•Jeffrey is a co-author of written materials and lectured for the Biotechnology: Patents, Licensing & FDA Practice course for the Patent Resources Group.
•Jeffrey is a co-inventor on two U.S. Patents and co-author of numerous scientific publications and presentations.
Before Edwards Wildman
Previously, Jeffrey was a Principal of Fish & Richardson P.C.; Corporate Counsel, Amgen Inc.; Patent Counsel and General Counsel, Kinetix Pharmaceuticals, Inc. (now Amgen Inc.); Associate, McAndrews, Held & Malloy, Ltd.; and Patent Agent, Fish & Neave. Before attending law school, Jeffrey was Senior Scientist, Medicinal Chemistry, The R.W. Johnson Pharmaceutical Research Institute (Johnson & Johnson); Research Assistant Professor, University of South Carolina, and an Undergraduate Research Scientist at the Upjohn Company.
Besides Edwards Wildman
Jeffrey is currently a member of the Asian Americans Advancing Justice/AAJC (Asian American Justice Center) Board of Directors. Jeffrey is Past President of the Asian American Lawyers Association of Massachusetts (AALAM) and served on their Executive Board for seven years, and he previously served on the National Asian Pacific American Bar Association (NAPABA) Board of Governors. He was also Co-Chair of the NAPABA 2009 National Convention Host Steering Committee in Boston and served on the NAPABA Committee on Regional Conferences. He previously served as co-chair of the Chemical Patent Practice Committee for the Boston Patent Law Association. Jeffrey is an avid tennis player and volunteered with the Massachusetts Special Olympics State Games (tennis) having previously served on its Tennis Management Team. Jeffrey is a member of the Rutgers University School of Law Minority Student Program (MSP) Legacy Alumni Campaign Committee and previously served as a member of the Board of Trustees of Kalamazoo College.
Currently admitted in DC, Illinois and Massachusetts and by the USPTO only. Florida Bar license pending.
• South Asia
Edwards Wildman's Jeffrey Hsi Appointed to the Board of Directors of the Asian Americans Advancing Justice AAJC (Asian American Justice Center)
October 6, 2014
Edwards Wildman Honored for Excellence in the IAM Patent 1000 - The World's Leading Patent Practitioners 2014
June 6, 2014
Edwards Wildman's Sang-yul Lee, Jeffrey Hsi, Emily Yu, and Bilal Zaheer Represent Firm at the National Asian Pacific American Bar Association Convention
November 12, 2013
Edwards Wildman's Jeffrey Hsi and Emily Yu Attend the Asian American Lawyers Association of Massachusetts Event, Reports Massachusetts Lawyers Weekly
February 14, 2013
Bio patents down, but not out in New England
June 26, 2009
Biotech, IT stalemate puts brakes on IP reform law
June 6, 2008
December 17, 2007
Obviousness ruling could have far-reaching impact
June 1, 2007
In the Minority
May 8, 2006
Hsi Elected President of Asian American Lawyers Association of Massachusetts
July 7, 2005 (Also at West Palm Beach, Florida Office)